To further characterize the role of DOCK1 in determining metformin sensitivity in pre-clinical models, we established four patient-derived HCC organoids (i.e., 1T, 2T, 3T, and 4T) for further in vitro analyses. The gene discussed is DOCK1; the disease is hepatocellular carcinoma.